Morniflumate
CAS No. 65847-85-0
Morniflumate ( UP-164; UP 164; UP164; Morniflu; Niflam )
Catalog No. M24668 CAS No. 65847-85-0
Morniflumate is a nonsteroidal anti-inflammatory drug. It is used to treat inflammation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 147 | In Stock |
|
10MG | 257 | In Stock |
|
25MG | 434 | In Stock |
|
50MG | 620 | In Stock |
|
100MG | 884 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMorniflumate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMorniflumate is a nonsteroidal anti-inflammatory drug. It is used to treat inflammation.
-
DescriptionMorniflumate is a nonsteroidal anti-inflammatory drug. It is used to treat inflammation.
-
SynonymsUP-164; UP 164; UP164; Morniflu; Niflam
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65847-85-0
-
Formula Weight395.4
-
Molecular FormulaC19H20F3N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESO=C(c1cccnc1Nc1cccc(C(F)(F)F)c1)OCCN1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cremonesi G, Cavalieri L. Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. J Int Med Res. 2015 Jun;43(3):290-302. doi: 10.1177/0300060514567212. Epub 2015 Apr 28. Review. PubMed PMID: 25921871.
molnova catalog
related products
-
Cepharanthine
Cepharanthine is a biscoclaurine alkaloid inhibiting tumor necrosis factor (TNF)-α-mediated NFκB stimulation, plasma membrane lipid peroxidation and platelet aggregation and suppressing cytokine production.
-
Itaconate-alkyne
Itaconate-alkyne is a bioorthogonal probe for quantitative and site-specific chemoproteomic profiling of itaconate in inflammatory macrophages and enables biochemical evaluation and proteomic analysis of its direct targets.
-
Secologanoside
Secologanoside shows anti-complementary, allelopathic, and anti-elastase activities.